In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID) announces a meeting of the aforementioned committee:
Times and Dates:
- 9:00 a.m.-5:00 p.m., EDT, July 13, 2017
- 9:00 a.m.-12:00 p.m., EDT, July 14, 2017
Place: Centers for Disease Control and Prevention, Global
Communications Center, Building 19, Auditorium B, 1600 Clifton Road
NE., Atlanta, Georgia, 30329.
Status: Open to the public, limited only by the space available.
Time will be available for public comment. The public is welcome to
submit written comments in advance of the meeting. Comments should be
submitted in writing by email to the contact person listed below. The
deadline for receipt is June 30, 2017. All requests must contain the
name, address, and organizational affiliation of the speaker, as well
as the topic being addressed. Written comments should not exceed one
single-spaced typed page in length and delivered in 3 minutes or less.
Members of the public who wish to provide public comments should plan
to attend the public comment session at the start time listed. Please
note that the public comment period may end before the time indicated
on the agenda, following the last call for comments. Written comments
received in advance of the meeting will be included in the official
record of the meeting.
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health
and Human Services regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related events
in settings where healthcare is provided; and (3) periodic updating of
CDC guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters for Discussion: The agenda will include updates on CDC's
activities for prevention of healthcare associated infections (HAIs),
an update on the Division of Healthcare Quality Promotion's (DHQP)
modeling activities, updates on the Guideline for Prevention of
Infection in Neonatal Intensive Care Unit (NICU) Patients and the
Guideline for Prevention of Infection in Healthcare Personnel, and
updates from the following HICPAC workgroups: The workgroup on
antibiotic stewardship principles for inclusion into clinical practice
guidelines, the workgroup on updating the CDC recommendation
categorization scheme, the workgroup on developing CDC recommendations
for products and practices, and the National Healthcare Safety Network
(NHSN) Surveillance Workgroup.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Erin Stone, M.A., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton
Road NE., Mailstop A-07, Atlanta, Georgia 30329, Telephone (404) 639-
4045. Email: firstname.lastname@example.org.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.